PPA
DNA icon

Parametric Portfolio Associates’s Ginkgo Bioworks DNA Stock Holding History

Parametric Portfolio Associates’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$249K Sell
1,542
-622
-29% -$121K ﹤0.01% 3356
2021
Q4 		$719K Buy
+2,164
New +$1.03M ﹤0.01% 2925

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
SIG
Senator Investment Group New York $2.74B AUM 55.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Parametric Portfolio Associates's DNA Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Ginkgo Bioworks (DNA) stake by 29% in Q1 2022, selling an estimated $121K and leaving 1,542 shares worth $249K. The position accounts for ﹤0.01% of the portfolio, ranked #3356.

Parametric Portfolio Associates first reported a position in DNA in Q4 2021 and has held it in 2 quarters since. The position peaked at $719K in Q4 2021. 190 funds tracked by Wall St. Rank hold DNA as of Q1 2022.

  • Parametric Portfolio Associates held 1,542 shares of Ginkgo Bioworks worth $249K as of Q1 2022.
  • Parametric Portfolio Associates sold 622 Ginkgo Bioworks shares in Q1 2022, an estimated $121K.
  • Ginkgo Bioworks made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3356 holding.
  • Parametric Portfolio Associates first reported a position in Ginkgo Bioworks in Q4 2021 and has held it in 2 quarters since.
  • Parametric Portfolio Associates's Ginkgo Bioworks position peaked at $719K in Q4 2021.
  • 190 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.